NEW YORK (GenomeWeb News) – Genomic Health said after the close of the market on Tuesday that its revenues in the fourth quarter increased 14 percent year over year.

Total revenues for the three months ended Dec. 31, 2013 came in at $68.8 million, up from $60.4 million, but short of the average analyst estimate of $69.2 million. Product revenues rose 12 percent to $67.1 million from $60 million, while contract revenues rose more than four-fold to $1.8 million from $429,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.